Intranasal ALN-RSV01 Administered to Adult Volunteers Experimentally Inoculated With Respiratory Syncytial Virus
Clinical trial NCT00496821 · COMPLETED
Trial details
- NCT number
- NCT00496821
- Sponsor
- Alnylam Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2007-07-01
- Enrollment
- 88
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.